ESC 365 - Characterizing malignant arrhythmias in patients with arrhythmic mitral valve prolapse insights from the SAFE MVP collaboration

EHRA Premium Access

Characterizing malignant arrhythmias in patients with arrhythmic mitral valve prolapse insights from the SAFE MVP collaboration

Session: Late-Breaking Science: ventricular tachycardia present and future

Topic: Clinical

Speaker: Professor A. Sabbag (Ramat Gan, IL)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Professor Avi Sabbag

Chaim Sheba Medical Center, Ramat Gan (Israel)

6 presentations

2 followers

11 more presentations in this session

Discussant review - SAVE-MVP

Speaker: Doctor M. Saba (London, GB)

Discussion - SAVE-MVP

Safety results from the european Affera Ventricular Arrhythmia Ablation Registry

Speaker: Professor F. Sacher (Bordeaux, FR)

Discussant review - AVAAR

Speaker: Professor G. Hindricks (Berlin, DE)

Discussion - AVAAR

Access the full session

Late-Breaking Science: ventricular tachycardia present and future

Speakers: Professor A. Sabbag, Doctor M. Saba, Professor F. Sacher, Professor G. Hindricks

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources